![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif)
eculizumab A human monoclonal antibody directed against terminal complement protein C5. Eculizumab binds to terminal complement protein C5, thereby blocking C5 cleavage into pro-inflammatory components and blocking the complement-mediated destruction of paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) | Alexion monoclonal antibody 5G1.1 monoclonal antibody anti-C5 | | ![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) | US brand name: | ![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) | Soliris | | ![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) | h5G1.1 | | ![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509175535im_/http://www.cancer.gov/images/spacer.gif) |